RareCyte snags $22 mln
Seattle-based RareCyte Inc, a creator of liquid and tissue biopsy analysis platforms, has closed $22 million in financing.
Seattle-based RareCyte Inc, a creator of liquid and tissue biopsy analysis platforms, has closed $22 million in financing.
Copyright PEI Media
Not for publication, email or dissemination